| T-cells produce acidic niches in lymph nodes to suppress their own effector functions H Wu, V Estrella, M Beatty, D Abrahams, A El-Kenawi, S Russell, ... Nature communications 11 (1), 4113, 2020 | 108 | 2020 |
| Adenovirus strategies for tissue-specific targeting MS Beatty, DT Curiel Advances in cancer research 115, 39-67, 2012 | 98 | 2012 |
| Localization of the N-terminus of minor coat protein IIIa in the adenovirus capsid C San Martín, JN Glasgow, A Borovjagin, MS Beatty, EA Kashentseva, ... Journal of molecular biology 383 (4), 923-934, 2008 | 71 | 2008 |
| Therapeutic potential of adult bone marrow–derived mesenchymal stem cells in prostate cancer bone metastasis D Chanda, T Isayeva, S Kumar, JA Hensel, A Sawant, G Ramaswamy, ... Clinical Cancer Research 15 (23), 7175-7185, 2009 | 67 | 2009 |
| HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms L Yue, V Sharma, NP Horvat, AA Akuffo, MS Beatty, C Murdun, C Colin, ... Blood, The Journal of the American Society of Hematology 135 (3), 191-207, 2020 | 48 | 2020 |
| Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon AA Akuffo, AY Alontaga, R Metcalf, MS Beatty, A Becker, JM McDaniel, ... Journal of Biological Chemistry 293 (16), 6187-6200, 2018 | 43 | 2018 |
| Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer M Poch, ML Hall, A Joerger, K Kodumudi, M Beatty, PP Innamarato, ... Oncoimmunology 7 (9), e1476816, 2018 | 39 | 2018 |
| Reactive myelopoiesis triggered by lymphodepleting chemotherapy limits the efficacy of adoptive T cell therapy P Innamarato, K Kodumudi, S Asby, B Schachner, ML Hall, A Mackay, ... Molecular Therapy 28 (10), 2252-2270, 2020 | 32 | 2020 |
| Expanded tumor-infiltrating lymphocytes from soft tissue sarcoma have tumor-specific function JE Mullinax, ML Hall, M Beatty, AM Weber, Z Sannasardo, T Svrdlin, ... Journal of Immunotherapy 44 (2), 63-70, 2021 | 26 | 2021 |
| Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patients AM Aydin, ML Hall, BL Bunch, H Branthoover, Z Sannasardo, A Mackay, ... International immunopharmacology 94, 107481, 2021 | 22 | 2021 |
| Cereblon harnesses Myc-dependent bioenergetics and activity of CD8+ T lymphocytes RS Hesterberg, MS Beatty, Y Han, MR Fernandez, AA Akuffo, ... Blood, The Journal of the American Society of Hematology 136 (7), 857-870, 2020 | 18 | 2020 |
| Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy DK Lester, C Burton, A Gardner, P Innamarato, K Kodumudi, Q Liu, ... Nature cancer 4 (2), 222-239, 2023 | 17 | 2023 |
| The factors affecting expansion of reactive tumor infiltrating lymphocytes (TIL) from bladder cancer and potential therapeutic applications AM Aydin, BL Bunch, M Beatty, A Hajiran, J Dhillon, AA Sarnaik, ... Frontiers in Immunology 12, 628063, 2021 | 9 | 2021 |
| Augmented adenovirus transduction of murine T lymphocytes utilizing a bi-specific protein targeting murine interleukin 2 receptor. MS Beatty, L Timares, DT Curiel Cancer gene therapy 22 (4), 222-222, 2015 | 8 | 2015 |
| Early recovery of myeloid-derived suppressor cells after allogeneic hematopoietic transplant: comparison of post-transplantation cyclophosphamide to standard graft-versus-host … B Oshrine, P Innamarato, H Branthoover, L Nagle, P Verdugo, ... Transplantation and cellular therapy 28 (4), 203. e1-203. e7, 2022 | 7 | 2022 |
| Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients MLS Hall, JK Teer, X Yu, H Branthoover, S Snedal, M Rodriguez-Valentin, ... Journal for ImmunoTherapy of Cancer 11 (10), 2023 | 6 | 2023 |
| Systemic and intravesical adoptive cell therapy of tumor-reactive T cells can decrease bladder tumor growth in vivo BL Bunch, J Morse, S Asby, J Blauvelt, AM Aydin, P Innamarato, A Hajiran, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 6 | 2020 |
| Combination nivolumab, CD137 agonism, and adoptive cell therapy with tumor-infiltrating lymphocytes for patients with metastatic melanoma MLS Hall, JE Mullinax, CA Cox, AM Hall, MS Beatty, J Blauvelt, ... Clinical Cancer Research 28 (24), 5317-5329, 2022 | 5 | 2022 |
| Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer S Bazargan, B Bunch, AME Ojwang ‘, J Blauvelt, A Landin, J Ali, ... Frontiers in Immunology 14, 1275375, 2023 | 4 | 2023 |
| Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumors P Innamarato, J Morse, A Mackay, S Asby, M Beatty, J Blauvelt, S Kidd, ... BMC cancer 21, 1-12, 2021 | 3 | 2021 |
